Recombinant DNA Vaccine Market, Global Outlook and Forecast 2022-2028

February 2022 | 78 pages | ID: RD44056EDB0DEN
Market Monitor Global

Abstracts

Recombinant DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

This report contains market size and forecasts of Recombinant DNA Vaccine in global, including the following market information:

Global Recombinant DNA Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant DNA Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Recombinant DNA Vaccine companies in 2021 (%)

The global Recombinant DNA Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Recombinant Protein Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant DNA Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant DNA Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant DNA Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant DNA Vaccine Market Segment Percentages, by Type, 2021 (%)

• Recombinant Protein Vaccine
• Gene-Based Vaccine

Global Recombinant DNA Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant DNA Vaccine Market Segment Percentages, by Application, 2021 (%)

• Human
• Animal

Global Recombinant DNA Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant DNA Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant DNA Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant DNA Vaccine revenues share in global market, 2021 (%)

Key companies Recombinant DNA Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Recombinant DNA Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• GSK
• Sanofi
• Zoties
• Elanco
• Boehringer-Ingelheim
• Indian Immunologicals
• Plumbline Life Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant DNA Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant DNA Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT DNA VACCINE OVERALL MARKET SIZE

2.1 Global Recombinant DNA Vaccine Market Size: 2021 VS 2028
2.2 Global Recombinant DNA Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant DNA Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Recombinant DNA Vaccine Players in Global Market
3.2 Top Global Recombinant DNA Vaccine Companies Ranked by Revenue
3.3 Global Recombinant DNA Vaccine Revenue by Companies
3.4 Global Recombinant DNA Vaccine Sales by Companies
3.5 Global Recombinant DNA Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant DNA Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant DNA Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant DNA Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Recombinant DNA Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Recombinant DNA Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant DNA Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Recombinant Protein Vaccine
  4.1.3 Gene-Based Vaccine
4.2 By Type - Global Recombinant DNA Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Recombinant DNA Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant DNA Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant DNA Vaccine Sales & Forecasts
  4.3.1 By Type - Global Recombinant DNA Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Recombinant DNA Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant DNA Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant DNA Vaccine Market Size, 2021 & 2028
  5.1.2 Human
  5.1.3 Animal
5.2 By Application - Global Recombinant DNA Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Recombinant DNA Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant DNA Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant DNA Vaccine Sales & Forecasts
  5.3.1 By Application - Global Recombinant DNA Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Recombinant DNA Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant DNA Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant DNA Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Recombinant DNA Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Recombinant DNA Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant DNA Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant DNA Vaccine Sales & Forecasts
  6.3.1 By Region - Global Recombinant DNA Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Recombinant DNA Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Recombinant DNA Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Recombinant DNA Vaccine Sales, 2017-2028
  6.4.3 US Recombinant DNA Vaccine Market Size, 2017-2028
  6.4.4 Canada Recombinant DNA Vaccine Market Size, 2017-2028
  6.4.5 Mexico Recombinant DNA Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Recombinant DNA Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Recombinant DNA Vaccine Sales, 2017-2028
  6.5.3 Germany Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.4 France Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.5 U.K. Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.6 Italy Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.7 Russia Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Recombinant DNA Vaccine Market Size, 2017-2028
  6.5.9 Benelux Recombinant DNA Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Recombinant DNA Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Recombinant DNA Vaccine Sales, 2017-2028
  6.6.3 China Recombinant DNA Vaccine Market Size, 2017-2028
  6.6.4 Japan Recombinant DNA Vaccine Market Size, 2017-2028
  6.6.5 South Korea Recombinant DNA Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Recombinant DNA Vaccine Market Size, 2017-2028
  6.6.7 India Recombinant DNA Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Recombinant DNA Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Recombinant DNA Vaccine Sales, 2017-2028
  6.7.3 Brazil Recombinant DNA Vaccine Market Size, 2017-2028
  6.7.4 Argentina Recombinant DNA Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Recombinant DNA Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Recombinant DNA Vaccine Sales, 2017-2028
  6.8.3 Turkey Recombinant DNA Vaccine Market Size, 2017-2028
  6.8.4 Israel Recombinant DNA Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Recombinant DNA Vaccine Market Size, 2017-2028
  6.8.6 UAE Recombinant DNA Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Recombinant DNA Vaccine Major Product Offerings
  7.1.4 Merck Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Recombinant DNA Vaccine Major Product Offerings
  7.2.4 GSK Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 GSK Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Recombinant DNA Vaccine Major Product Offerings
  7.3.4 Sanofi Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Sanofi Key News
7.4 Zoties
  7.4.1 Zoties Corporate Summary
  7.4.2 Zoties Business Overview
  7.4.3 Zoties Recombinant DNA Vaccine Major Product Offerings
  7.4.4 Zoties Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Zoties Key News
7.5 Elanco
  7.5.1 Elanco Corporate Summary
  7.5.2 Elanco Business Overview
  7.5.3 Elanco Recombinant DNA Vaccine Major Product Offerings
  7.5.4 Elanco Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Elanco Key News
7.6 Boehringer-Ingelheim
  7.6.1 Boehringer-Ingelheim Corporate Summary
  7.6.2 Boehringer-Ingelheim Business Overview
  7.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Major Product Offerings
  7.6.4 Boehringer-Ingelheim Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Boehringer-Ingelheim Key News
7.7 Indian Immunologicals
  7.7.1 Indian Immunologicals Corporate Summary
  7.7.2 Indian Immunologicals Business Overview
  7.7.3 Indian Immunologicals Recombinant DNA Vaccine Major Product Offerings
  7.7.4 Indian Immunologicals Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 Indian Immunologicals Key News
7.8 Plumbline Life Sciences
  7.8.1 Plumbline Life Sciences Corporate Summary
  7.8.2 Plumbline Life Sciences Business Overview
  7.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Major Product Offerings
  7.8.4 Plumbline Life Sciences Recombinant DNA Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 Plumbline Life Sciences Key News

8 GLOBAL RECOMBINANT DNA VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Recombinant DNA Vaccine Production Capacity, 2017-2028
8.2 Recombinant DNA Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant DNA Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RECOMBINANT DNA VACCINE SUPPLY CHAIN ANALYSIS

10.1 Recombinant DNA Vaccine Industry Value Chain
10.2 Recombinant DNA Vaccine Upstream Market
10.3 Recombinant DNA Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Recombinant DNA Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Recombinant DNA Vaccine in Global Market
Table 2. Top Recombinant DNA Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant DNA Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant DNA Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant DNA Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant DNA Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant DNA Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Recombinant DNA Vaccine Product Type
Table 9. List of Global Tier 1 Recombinant DNA Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant DNA Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant DNA Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant DNA Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant DNA Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Recombinant DNA Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant DNA Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant DNA Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Recombinant DNA Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant DNA Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant DNA Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant DNA Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant DNA Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant DNA Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant DNA Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant DNA Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant DNA Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant DNA Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant DNA Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant DNA Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant DNA Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant DNA Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant DNA Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant DNA Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant DNA Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant DNA Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant DNA Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Recombinant DNA Vaccine Product Offerings
Table 48. Merck Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Recombinant DNA Vaccine Product Offerings
Table 51. GSK Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Recombinant DNA Vaccine Product Offerings
Table 54. Sanofi Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Zoties Corporate Summary
Table 56. Zoties Recombinant DNA Vaccine Product Offerings
Table 57. Zoties Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Elanco Corporate Summary
Table 59. Elanco Recombinant DNA Vaccine Product Offerings
Table 60. Elanco Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Boehringer-Ingelheim Corporate Summary
Table 62. Boehringer-Ingelheim Recombinant DNA Vaccine Product Offerings
Table 63. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Indian Immunologicals Corporate Summary
Table 65. Indian Immunologicals Recombinant DNA Vaccine Product Offerings
Table 66. Indian Immunologicals Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Plumbline Life Sciences Corporate Summary
Table 68. Plumbline Life Sciences Recombinant DNA Vaccine Product Offerings
Table 69. Plumbline Life Sciences Recombinant DNA Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Recombinant DNA Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Recombinant DNA Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Recombinant DNA Vaccine Production by Region, 2017-2022 (K Units)
Table 73. Global Recombinant DNA Vaccine Production by Region, 2023-2028 (K Units)
Table 74. Recombinant DNA Vaccine Market Opportunities & Trends in Global Market
Table 75. Recombinant DNA Vaccine Market Drivers in Global Market
Table 76. Recombinant DNA Vaccine Market Restraints in Global Market
Table 77. Recombinant DNA Vaccine Raw Materials
Table 78. Recombinant DNA Vaccine Raw Materials Suppliers in Global Market
Table 79. Typical Recombinant DNA Vaccine Downstream
Table 80. Recombinant DNA Vaccine Downstream Clients in Global Market
Table 81. Recombinant DNA Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant DNA Vaccine Segment by Type
Figure 2. Recombinant DNA Vaccine Segment by Application
Figure 3. Global Recombinant DNA Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant DNA Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant DNA Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant DNA Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant DNA Vaccine Revenue in 2021
Figure 9. By Type - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant DNA Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant DNA Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 19. US Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 33. China Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant DNA Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant DNA Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant DNA Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant DNA Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant DNA Vaccine by Region, 2021 VS 2028
Figure 50. Recombinant DNA Vaccine Industry Value Chain
Figure 51. Marketing Channels